X
UK biotech Orchard plans $172.5m US IPO to fund rare disease R&D
https://pharmaphorum.com/news/uk-biotech-orchard-plans-172-5m-us-ipo-to-fund-rare-disease-rd/
IPO
Cancer blood test firm Grail mulls IPO
Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
Clovis looks for new drugs after Rubraca success
US biotech looks to bolster pipeline.
Biotech IPO market heats up as BioHaven’s debut impresses
BioHaven raises $168 million with biggest biotech IPO seen this year.
1 2
